Afstyla and Dupilumab Subcutaneous
Determining the interaction of Afstyla and Dupilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla-Dupixent
- Afstyla-Duplex T Topical
- Afstyla-Durachol
- Afstyla-Duraclon
- Afstyla-Duraclon injection
- Afstyla-Duraflu
- Dupilumab Subcutaneous-Afstyla recombinant
- Dupilumab Subcutaneous-Aftera
- Dupilumab Subcutaneous-Aftertest Topical Pain Relief
- Dupilumab Subcutaneous-Agalsidase beta
- Dupilumab Subcutaneous-Agalsidase beta Intravenous
- Dupilumab Subcutaneous-Agenerase